Quantitative determination of voglibose in pharmaceutical tablets using high-performance liquid chromatography–fluorescence detection with post-column derivatization and mass spectrometric detection
- 26 September 2006
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 42 (3), 328-333
- https://doi.org/10.1016/j.jpba.2006.04.018
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Voglibose (Basen®, AO-128), One of the Most Important α-Glucosidase InhibitorsCurrent Medicinal Chemistry, 2006
- α-Glucosidase inhibitor reduces the progression of carotid intima-media thicknessDiabetes Research and Clinical Practice, 2005
- Determination of the structures of four new isomeric cyclitolsCarbohydrate Research, 2004
- Different effects of two α-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) levelJournal of Diabetes and its Complications, 2004
- Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patientsDiabetes Research and Clinical Practice, 2002
- Analysis of carbohydrates in drinks by high-performance liquid chromatography with a dynamically modified amino column and evaporative light scattering detectionJournal of Chromatography A, 2000
- Development and validation of liquid chromatography and capillary electrophoresis methods for acarbose determination in pharmaceutical tabletsJournal of Pharmaceutical and Biomedical Analysis, 1998
- Analysis of the antidiabetic drug acarbose by capillary electrophoresisJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- The evaporative light scattering detector: some applications in pharmaceutical analysisTrAC Trends in Analytical Chemistry, 1997
- Controle de certains systemes de chromatographie liquide haute performance à láide d'un détecteur évaporatif à diffusion de lumièreJournal of Chromatography A, 1989